Petersen L C, Boel E, Johannessen M, Foster D
Novo-Nordisk A/S, Novo Allé, Bagsvaerd, Denmark.
Biochemistry. 1990 Apr 10;29(14):3451-7. doi: 10.1021/bi00466a005.
In contrast to most other serine proteases, tissue-type plasminogen activator (t-PA) possesses enzymatic activity as the one-chain zymogen form. The hypothesis that lysine residues 277 or 416 may be involved in stabilization of an active conformation of one-chain t-PA via salt-bridge formation with aspartic acid residue 477 was tested by site-directed mutagenesis. Four recombinant t-PA mutants were constructed. The amidolytic activities of these analogues were compared to that of authentic t-PA. Substitution of arginine-275 provided an analogue [( R275G]t-PA) resistant to plasmin cleavage. The amidolytic activity of [R275G]t-PA was comparable to that of authentic one-chain t-PA, and so was the activity of [R275L,K277L]t-PA, in which additional substitution of lysine residue 277 was carried out. This suggested that its presence was nonessential for obtaining one-chain t-PA activity. In contrast, substitution of lysine residue 416 to obtain [K416S]t-PA and [K416S,H417T]t-PA resulted in substantial quenching of amidolytic one-chain activity. As expected, the amidolytic activities of the two-chain forms were less affected by the substitution. Involvement of lysine residue 416 in one-chain t-PA activity was also indicated by decreased activities of [K416S]t-PA and [K416S,H417T]t-PA with plasminogen as the substrate. The one-chain activity of the lysine residue 416 substitution analogues was partially restored in the presence of fibrin. This could indicate that strong ligands such as fibrin might provide an alternative stabilization of the active conformation of one-chain t-PA.
与大多数其他丝氨酸蛋白酶不同,组织型纤溶酶原激活剂(t-PA)以单链酶原形式具有酶活性。通过定点诱变测试了赖氨酸残基277或416可能通过与天冬氨酸残基477形成盐桥参与稳定单链t-PA活性构象的假说。构建了四种重组t-PA突变体。将这些类似物的酰胺水解活性与天然t-PA的活性进行了比较。精氨酸-275的取代产生了一种对纤溶酶裂解有抗性的类似物[(R275G)]t-PA。[R275G]t-PA的酰胺水解活性与天然单链t-PA的活性相当,[R275L,K277L]t-PA的活性也是如此,其中赖氨酸残基277进行了额外取代。这表明其存在对于获得单链t-PA活性并非必不可少。相反,赖氨酸残基416的取代以获得[K416S]t-PA和[K416S,H417T]t-PA导致酰胺水解单链活性大幅降低。正如预期的那样,双链形式的酰胺水解活性受取代的影响较小。以纤溶酶原为底物时,[K416S]t-PA和[K416S,H417T]t-PA活性降低也表明赖氨酸残基416参与单链t-PA活性。在纤维蛋白存在下,赖氨酸残基416取代类似物的单链活性部分恢复。这可能表明诸如纤维蛋白之类的强配体可能为单链t-PA的活性构象提供替代的稳定性。